|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Hayden, P. J.; Roddie, C.; Bader, P.; Basak, G. W.; Bonig, H.; Bonini, C.; Chabannon, C.; Ciceri, F.; Corbacioglu, S.; Ellard, R.; Sanchez-Guijo, F.; Jaeger, U.; Hildebrandt, M.; Hudecek, M.; Kersten, M. J.; Koehl, U.; Kuball, J.; Mielke, S.; Mohty, M.; Murray, J.; Nagler, A.; Rees, J.; Rioufol, C.; Saccardi, R.; Snowden, J. A.; Styczynski, J.; Subklewe, M.; Thieblemont, C.; Topp, M.; Ispizua, A. U.; Chen, D.; Vrhovac, R.; Gribben, J. G.; Kroeger, N.; Einsele, H. und Yakoub-Agha, I
(2022):
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
In: Annals of Oncology, Bd. 33, Nr. 3: S. 259-275
2016
Vrhovac, R.; Labopin, M.; Ciceri, F.; Finke, J.; Holler, E.; Tischer, J.; Lioure, B.; Gribben, J.; Kanz, L.; Blaise, D.; Dreger, P.; Held, G.; Arnold, R.; Nagler, A. und Mohty, M.
(2016):
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes.
In: Bone Marrow Transplantation, Bd. 51, Nr. 2: S. 186-193